Literature DB >> 6389317

Epidemiology of neural tube defects in Germany.

M Koch, W Fuhrmann.   

Abstract

A survey is made of the epidemiologic studies of neural tube defects (NTD) in Germany. A temporary increase is noted in the prevalence of NTD at birth for the time during and shortly after the Second World War, followed by a downward trend thereafter. Thus an earlier observation of Lenz (1965) could be confirmed. Falling rates of NTD were also reported from various other countries in recent years. No convincing etiological explanation is available so far. The current prevalence of NTD at birth can be estimated for Germany to be about 1.0-1.5 per thousand newborns with about an even distribution to anencephalus and spina bifida.

Entities:  

Mesh:

Year:  1984        PMID: 6389317     DOI: 10.1007/bf00279300

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  47 in total

1.  ANENECEPHALY IN FRANCE.

Authors:  J FREZAL; J KELLEY; M L GUILLEMOT; M LAMY
Journal:  Am J Hum Genet       Date:  1964-09       Impact factor: 11.025

2.  [ON THE INCIDENCE OF ANENCEPHALUS AND SPINA BIFIDA IN THE ADMINISTRATIVE AREA OF MUENSTER].

Authors:  W TUENTE
Journal:  Z Mensch Vererb Konstitutionsl       Date:  1964-06-22

3.  Congenital abnormalities.

Authors:  V P COFFEY; W J JESSOP
Journal:  Ir J Med Sci       Date:  1955-01       Impact factor: 1.568

4.  [Deformities and environmental factors].

Authors:  N ARESIN; K H SOMMER
Journal:  Zentralbl Gynakol       Date:  1950

5.  The sex ratio in spina bifida.

Authors:  W H James
Journal:  J Med Genet       Date:  1979-10       Impact factor: 6.318

6.  Anencephaly and spina bifida in Israel.

Authors:  L Naggan
Journal:  Pediatrics       Date:  1971-03       Impact factor: 7.124

Review 7.  The reduction of anencephalic and spina bifida births by maternal serum alphafetoprotein screening.

Authors:  M A Ferguson-Smith
Journal:  Br Med Bull       Date:  1983-10       Impact factor: 4.291

8.  Incidence and prevalence as measures of the frequency of birth defects.

Authors:  E B Hook
Journal:  Am J Epidemiol       Date:  1982-11       Impact factor: 4.897

9.  Neural tube defects in New South Wales, Australia.

Authors:  B Field
Journal:  J Med Genet       Date:  1978-10       Impact factor: 6.318

10.  An epidemiologic study of neural tube defects in Los Angeles County II. Etiologic factors in an area with low prevalence at birth.

Authors:  L E Sever
Journal:  Teratology       Date:  1982-06
View more
  7 in total

1.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. EUROCAT Working Group.

Authors: 
Journal:  J Epidemiol Community Health       Date:  1991-03       Impact factor: 3.710

3.  Etiology of chronic renal failure in Turkish children.

Authors:  A Sirin; S Emre; H Alpay; A Nayir; I Bilge; F Tanman
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

4.  Sibs of probands with neural tube defects--a study in the Federal Republic of Germany.

Authors:  M Koch; W Fuhrmann
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Neural tube defects in Beijing-Tianjin area of China. Urban-rural distribution and some other epidemiological characteristics.

Authors:  Z H Lian; H Y Yang; Z Li
Journal:  J Epidemiol Community Health       Date:  1987-09       Impact factor: 3.710

6.  Congenital malformations of the central nervous system in a 1-year birth cohort followed to the age of 14 years.

Authors:  L von Wendt; P Rantakallio
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

7.  Neural tube defects in native fars ethnicity in northern iran.

Authors:  Mj Golalipour; L Najafi; Aa Keshtkar
Journal:  Iran J Public Health       Date:  2010-09-30       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.